Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 26 September 2023 30 September 2024 30 September 2024 15165393 Dr Jacqueline Abbas iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15165393 2023-09-25 15165393 2024-09-30 15165393 2023-09-26 2024-09-30 15165393 frs-core:CurrentFinancialInstruments 2024-09-30 15165393 frs-bus:PrivateLimitedCompanyLtd 2023-09-26 2024-09-30 15165393 frs-bus:FilletedAccounts 2023-09-26 2024-09-30 15165393 frs-bus:Micro-entities 2023-09-26 2024-09-30 15165393 frs-bus:AuditExempt-NoAccountantsReport 2023-09-26 2024-09-30 15165393 frs-bus:Director1 2023-09-26 2024-09-30
Registered number: 15165393
Pathway Biosolutions Ltd
Unaudited Financial Statements
For The Year Ended 30 September 2024
Balance Sheet
Registered number: 15165393
2024
£
Fixed assets 545
Current assets 3,127
Prepayments and accrued income 19,170
Creditors: Amounts Falling Due Within One Year (5,784 )
NET CURRENT ASSETS 16,513
TOTAL ASSETS LESS CURRENT LIABILITIES 17,058
Accruals and deferred income (3,353 )
NET ASSETS 13,705
CAPITAL AND RESERVES 13,705

Notes

1. General Information
Pathway Biosolutions Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15165393 . The registered office is 43 Horseshoe Crescent, Beaconsfield, HP9 1LJ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Jacqueline Abbas
Director
14/05/2025